Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization

Long‐term exposure to lipid‐lowering drugs might affect Parkinson's disease (PD) risk. We conducted Mendelian randomization analyses where genetic variants indexed expected effects of modulating lipid‐lowering drug targets on PD. Statin exposure was not predicted to increase PD risk, although r...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Dylan M., Bandres‐Ciga, Sara, Heilbron, Karl, Hinds, David, Noyce, Alastair J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693098/
https://www.ncbi.nlm.nih.gov/pubmed/32841444
http://dx.doi.org/10.1002/ana.25880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693098/
https://www.ncbi.nlm.nih.gov/pubmed/32841444
http://dx.doi.org/10.1002/ana.25880

Ejemplares similares